The Medical Technology and Advocacy of Amicus Therapeutics
Amicus Therapeutics, Inc (In Nasdaq: FOLD) is right now a leading global biotechnology company that is successfully at the forefront of the thriving advanced therapies that attempt to address and treat the range of devastating orphan and rare diseases in the world. The range of pipeline treatment developed by the company proves promising for the genetic diseases that challenge the civil society today.
Right now the major and leading product by Amicus Therapeutics is the highly customized medicine, migalastat, which is now in its late-stage of development in treating individuals diagnosed with Fabry disease that is based on their genetics.
Another potential high-ticket product in the company is the SD-101, which promises excellent remedy for those people suffering from connective tissue disorder Epidermolysis Bullosa (EB).
There is also another uniquely structured Pompe disease ERT under the pipeline of the company called ATB200/AT2221 and will provide even more quality reputation for the enterprise. These products are what make the company one of the top inventive research firms today.
The Rise and Goal of Amicus Therapeutics
The biotechnology company is right now making sure that rare and orphan diseases are not left unaddressed (https://www.indeed.com/q-Amicus-Therapeutics-l-Cranbury,-NJ-jobs.html). The growth of the Amicus Therapeutics credits itself from the platform technologies that their researchers developed for people living with such unimaginable rare and debilitating diseases
The goal of the company is simple: to provide care and to make sure that the innovative treatments of the firm reflect in the clinical programs and the public view of the company. This is in relation to the mission of Amicus to make meaningful contributions to the lives of patients and their caregivers.
Work With Amicus
There are numerous career opportunities with Amicus Therapeutics, and the inventive and purposeful vision of the company makes sure that the efforts of the employees are appreciated. The company also stands out in its advocacy for being an Equal Opportunity Employer that will not judge applicants on their qualities based on race, sex, religion, color, national origin, disability, age or any other attributes protected by applicable state, federal and local laws.
Amicus Therapeutics has its headquarters at 1 Cedar Brook Drive Cranbury in NJ 08512, United States, with 201-500 passionate employees.